1. Lu, Linchao, Varshney, Shweta, Yuan, Youxi, Haltiwanger, Robert S, Stanley, Pamela. 2023. In vivo evidence for GDP-fucose transport in the absence of transporter SLC35C1 and putative transporter SLC35C2. In The Journal of biological chemistry, 299, 105406. doi:10.1016/j.jbc.2023.105406. https://pubmed.ncbi.nlm.nih.gov/38270391/
2. Lu, Linchao, Hou, Xinghua, Shi, Shaolin, Körner, Christian, Stanley, Pamela. 2010. Slc35c2 promotes Notch1 fucosylation and is required for optimal Notch signaling in mammalian cells. In The Journal of biological chemistry, 285, 36245-54. doi:10.1074/jbc.M110.126003. https://pubmed.ncbi.nlm.nih.gov/20837470/
3. Qi, Chunhui, Cao, Bin, Gong, Zhiwen, Zhao, Yan, Chen, Yingchun. 2025. SLC35C2 promotes stemness and progression in hepatocellular carcinoma by activating lipogenesis. In Cellular signalling, 127, 111589. doi:10.1016/j.cellsig.2025.111589. https://pubmed.ncbi.nlm.nih.gov/39765278/
4. Plasterer, Cody, Tsaih, Shirng-Wern, Peck, Amy R, Rui, Hallgeir, Flister, Michael J. 2019. Neuronatin is a modifier of estrogen receptor-positive breast cancer incidence and outcome. In Breast cancer research and treatment, 177, 77-91. doi:10.1007/s10549-019-05307-8. https://pubmed.ncbi.nlm.nih.gov/31165373/